For the Inventor, By the Inventor

Enter inventor name

Indianapolis, IN, United States of America

Gary A Koppel

USPTO Granted Patents = 50 (Patent Applications = 7)

CIPO Patents = 2

EPO Patents = 3

Average Co-Inventor Count = 1.8

ph-index = 12

Forward Citations = 486(Granted Patents)

Forward Citations (Not Self Cited) = 447(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

37 out of 4,446

Eli Lilly and Company

Revaax Pharmaceuticals, LLC

Azevan Pharmaceuticals, Inc.

Years Active: 1976-2017

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Beta-Lactam Compounds

Neurotherapeutic Treatment

Vasopressin Antagonists

Cannabinoid Receptor Antagonists

Antibody Drug-Conjugates

Azetidinone Analogs

Cephalosporin Antibiotics

Behavioral Disorders Treatment

Immunoglobulin Conjugates

Angiogenesis

Thiazolidine Derivatives

Antibiotic Synthesis

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9597314 - Beta-lactamylalkanoic acids for treating premenstrual disorders (2017-03-21),

2. 8426400 - β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists (2013-04-23),

3. 8048874 - Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists (2011-11-01),

4. 7998991 - Neurotherapeutic treatment for sexual dysfunction (2011-08-16),

5. 7842683 - Neurotherapeutic compositions and method (2010-11-30),

6. 7833998 - Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions (2010-11-16),

7. 7268125 - [object Object] (2007-09-11),

8. 7166626 - Therapeutic treatment for sexual dysfunction (2007-01-23),

9. 7119083 - [object Object] (2006-10-10),

10. 6627625 - Treatment of behavioral disorders with &bgr;-lactam compounds (2003-09-30),

11. 6610681 - Neurotherapeutic clavulanate composition and method (2003-08-26),

12. 6610680 - Non-peptidyl vasopressin V1A antagonists (2003-08-26),

13. 6521611 - Non-peptidyl vasopressin V1a antagonists (2003-02-18),

14. 6489319 - Neurotherapeutic use of carboxypeptidase inhibitors (2002-12-03),

15. 6426342 - Use of &bgr;-lactamase inhibitors as neuroprotectants (2002-07-30),

Title: Gary A Koppel - Pioneering Inventor from Indianapolis

Introduction: Gary A Koppel is a distinguished inventor based in Indianapolis, IN, known for his groundbreaking contributions to various fields.

Latest Patents: Gary A Koppel holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Gary A Koppel has consistently pushed the boundaries of innovation, with his inventions making a significant impact in their respective industries.

Collaborations: Throughout his career, Gary A Koppel has collaborated with leading companies, research institutions, and universities to bring his inventions to life, further solidifying his reputation as a visionary inventor.

Conclusion: Gary A Koppel's passion for innovation and his relentless drive to create have cemented his legacy as a pioneering inventor, inspiring future generations to think outside the box and pursue their inventive ideas.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…